Posted inBiotechnology
Posted inBiotechnology
$2.5M DoD grant supports targeted therapy development for triple-negative breast cancer
Weill Cornell Medicine has secured a $2.5 million, three-year Department of Defense (DoD) Breakthrough Award to create new therapies for…


















